6-bromo-1H,2H,3H-pyrrolo[3,2-b]pyridine, 95.0%, 250mg

3-(4-pyridinyl)-1H-pyrazole-5-carboxylic acid hydrochloride hydrate, 95.0%, 1g

(S)-Methyl 3-(7-bromo-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)propanoate, 97.0%, 5g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((tert-butyldimethylsilyl)oxy)propanoic acid, 95+%, 100mg

4-Bromo-2-furoic acid, 95.0%, 10g

2-(2-Chloroquinazolin-4-yl)acetamide, 95.0%, 5g

N,N-Dimethyl-1,3-propanediamine Dihydroiodide>97.0%(T)1g

(2S,3aS,6aS)-1-(tert-Butoxycarbonyl)octahydrocyclopenta[b]pyrrole-2-carboxylic acid, 97%, 500mg

(2-FLUORO-4,6-DIMETHOXYPHENYL)BORONIC ACID, 95%, 100mg

2-Bromo-1-(bromomethyl)-4-nitrobenzene, 95.0%, 25g

6-AMINO-2-(TRIFLUOROMETHYL)PYRIMIDIN-4-OL, 95.0%, 2.5g

[(2S)-OXETAN-2-YL]METHANOL, 95%, 1g

4-Phenyl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine, 95.0%, 500mg